Traditional drug discovery is slow, costly, and often disconnected from the real biology of patients. Meanwhile, biobank resources like the UK Biobank gather vast genomic, proteomic, and phenotypic datasets — a treasure full of insights waiting to be discovered.
But here’s the challenge: How do we translate millions of patient data points into actionable discoveries? The answer lies in AI-powered biobank analysis, which enables us to identify causal pathways, discover novel subgroups, and guide smarter therapeutic decisions.
Webinar insights:
- Uncover hidden phenotypes and subgroups using AI applied to large-scale patient data.
- Support drug repurposing and indication expansion through biobank insights.
- Accelerate target identification with proteomics-driven discovery.
In this session, we’ll share real-world examples from the UK Biobank that show how AI-based analysis impacts novel discoveries based on patient data.
Offered Free by: Ardigen
See All Resources from: Ardigen
